Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function

被引:430
作者
Yawata, M
Yawata, N
Draghi, M
Little, AM
Partheniou, F
Parham, P [1 ]
机构
[1] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA
[2] Royal Free Hosp, Dept Haematol, London NW3 2QG, England
[3] Anthony Nolan Trust, Histocompatibil Labs, London NW3 2QG, England
关键词
D O I
10.1084/jem.20051884
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Interactions between killer cell immunoglobulin-like receptors (KIRs) and human leukocyte antigen (HLA) class I ligands regulate the development and response of human natural killer (NK) cells. Natural selection drove an allele-level group A KIR haplotype and the HLA-C1 ligand to unusually high frequency in the Japanese, who provide a particularly informative population for investigating the mechanisms by which KIR and HLA polymorphism influence NK cell repertoire and function. HLA class I ligands increase the frequencies of NK cells expressing cognate KIR, an effect modified by gene dose, KIR polymorphism, and the presence of other cognate ligand-receptor pairs. The five common Japanese KIR3DLI allotypes have distinguishable inhibitory capacity, frequency of cellular expression, and level of cell surface expression as measured by antibody binding. Although KIR haplotypes encoding 3DL1*001 or 3DL1*005, the strongest inhibitors, have no activating KIR, the dominant haplotype encodes a moderate inhibitor, 3DL1*01502, plus functional forms of the activating receptors 2DL4 and 2DS4. In the population, certain combinations of KIR and HLA class I ligand are overrepresented or underrepresented in women, but not men, and thus influence female fitness and survival. These findings show how KIR-HLA interactions shape the genetic and phenotypic KIR repertoires for both individual humans and the population.
引用
收藏
页码:633 / 645
页数:13
相关论文
共 61 条
  • [1] Natural selection drives recurrent formation of activating killer cell immunoglobulin-like receptor and Ly49 from inhibitory homologues
    Abi-Rached, L
    Parham, P
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (08) : 1319 - 1332
  • [2] Complete elucidation of a minimal class I MHC natural killer cell receptor haplotype
    Anderson, SK
    Dewar, K
    Goulet, ML
    Leveque, G
    Makrigiannis, AP
    [J]. GENES AND IMMUNITY, 2005, 6 (06) : 481 - 492
  • [3] KIR3DL1 polymorphisms that affect NK cell inhibition by HLA-Bw4 ligand
    Carr, WH
    Pando, MJ
    Parham, P
    [J]. JOURNAL OF IMMUNOLOGY, 2005, 175 (08) : 5222 - 5229
  • [4] Hierarchy of resistance to cervical neoplasia mediated by combinations of killer immunoglobulin-like receptor and human leukocyte antigen loci
    Carrington, M
    Wang, S
    Martin, MP
    Gao, XJ
    Schiffman, M
    Cheng, J
    Herrero, R
    Rodriguez, AC
    Kurman, R
    Mortel, R
    Schwartz, P
    Glass, A
    Hildesheim, A
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (07) : 1069 - 1075
  • [5] Da Silva JAP, 1999, ANN NY ACAD SCI, V876, P102
  • [6] Acquisition of Ly49 receptor expression by developing natural killer cells
    Dorfman, JR
    Raulet, DH
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (04) : 609 - 618
  • [7] Single-cell analysis of the human NK cell response to missing self and its inhibition by HLA class I
    Draghi, M
    Yawata, N
    Gleimer, M
    Yawata, M
    Valiante, NM
    Parham, P
    [J]. BLOOD, 2005, 105 (05) : 2028 - 2035
  • [8] Identification of an HLA-B7 serological variant and its characterization by sequencing based typing
    Dunn, PPJ
    Carter, V
    Dunn, A
    Day, S
    Fuggle, SV
    Ross, J
    Cavanagh, G
    [J]. TISSUE ANTIGENS, 2000, 55 (01): : 71 - 73
  • [9] EIBEN B, 1990, AM J HUM GENET, V47, P656
  • [10] EWENS WJ, 1972, THEOR POPUL BIOL, V3, P87, DOI 10.1016/0040-5809(72)90035-4